The 2020 Worldwide Pharma & Biotech Industry R&D Scene
Infographic Of R&D KPIs
INFOGRAPHIC: A snapshot of the industry in key performance indicators, taken in early 2020.
You may also be interested in...
Join us for a quick audio roundup of five useful things to know from Scrip’s recent coverage of the global biopharmaceutical industry.
The firm’s potential new therapy for the negative symptoms of schizophrenia is now in the hands of the US Food and Drug Administration – some have concerns over whether the supporting data will be enough.
One of the architects of AstraZeneca’s burgeoning cancer portfolio, oncology R&D head Susan Galbraith is making sure the firm does not rest on its laurels. She talked to Scrip about what’s coming next from the UK major’s cancer pipeline.